Weight Loss Telemedicine
Helping you shape a healthier future.
Having obesity or excess weight significantly increases the risk of developing conditions such as type 2 diabetes and heart disease. This means that weight management plays a vital role in preventive care, and can take the form of regular exercise and a healthy diet.Talking with your doctor about weight loss treatment options can be a step in the right direction. Our board-certified providers can help you develop a weight management plan that supports your long-term health and personal fitness.
Weight Loss Management patients MUST sign up for the DPC Membership in order to receive treatment: Sign Up Now
​
View our common telehealth weight loss treatments to learn more: generic Semaglutide and Tirzapetide
Common Weight Loss Treatments We Offer Through Telehealth
Tirzapetide + BPC 157
Tirzepatide + BPC-157 How it works: This specialty medication brings together Tirzepatide (the active ingredient in some GLP-1 medications like Mounjaro) and BPC-157 (studied for decades for its role as an anti-inflammatory agent) for noticeable weight-loss results. Tirzepatide activates GLP-1 and GIP receptors in the body, which can reduce appetite, increase feelings of fullness, and promote weight loss. At the same time, BPC-157 addresses the underlying inflammation believed to contribute to obesity — potentially helping you drop more weight and enjoy better overall health.
Semaglutide + BPC 157
Semaglutide + BPC-157 What is a compounded GLP-1 medication? How it works: Semaglutide (the active ingredient in some GLP-1s such as Ozempic and Wegovy) joins forces with the anti-inflammatory powers of BPC-157 for effective weight loss. Semaglutide binds to GLP-1 receptors in the body, causing the stomach to empty at a slower rate and also regulating the brain’s hunger signals. As a result, you feel fuller faster, end up eating less, and lose more weight. BPC-157 (which stands for Body Protection Compound 157) is based on a protective compound that lives in the human stomach. BPC-157 works by triggering the formation of new blood vessels, which may promote healing and cause cells to regenerate at a faster pace. BPC-157 along with Semaglutide is a winning combination for weight loss.
How to administer
These medications are self injected once a week with a small, thin needle. Please follow the instructions of your healthcare provider. If you have any questions, you can contact your patient care team.
Are Compounded medications covered by insurance
While compounded GLP-1 medications are not covered by insurance, they are typically less expensive than non-compounded name brand drugs like Wegovy, Ozempic, and Mounjaro. For that reason, they can be an affordable option for uninsured patients and patients whose insurance won’t cover other GLP-1 drugs. Your healthcare provider may also prescribe a compounded medication interimly, as the team conducts a benefits check to see whether your insurance provider covers a name brand option.
How does the Wells Pharmacy Network ensure the safety of their medication?
Wells Pharmacy Network operates out of a 20,500-square-foot, industry-leading facility in Ocala, Florida that enables it to prepare compounded medications with precision and efficiency. The pharmacy invests in advanced technology and state-of-the-art equipment, adheres to the highest-quality protocols, and employs top talent. Features include: If you have additional questions about compounded GLP-1 medications, do not hesitate to contact your LifeMD care team through the patient portal or by calling (800) 304-2656. For more information on the Wells Pharmacy Network and its safety measures, visit https://wellsrx.com/ GLP-1 receptor agonists—including semaglutide, liraglutide, dulaglutide, and tirzepatide—have been prescribed (on-and-off label) for weight management, including obesity, along with a reduced caloric diet and increased physical activity. Take precaution with, and read all warnings concerning, GLP-1s, as they may cause serious side effects, including a risk of thyroid c-cell tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC (medullary thyroid carcinoma) or MEN 2 (multiple endocrine neoplasia syndrome). See important warnings & safety info about these medications. Third-party independent testing to validate in-house test methods Chemicals purchased through FDA-registered facilities Five-point quality control process Images of the contents of every order captured during packing and shipping Experienced clinical pharmacists and registered pharmacy technicians to process and verify all prescription orders PhD biochemist on site to manage Quality Control laboratory testing process Sterility reports available upon request for every order.
​
GLP-1 receptor agonists—including semaglutide, liraglutide, dulaglutide, and tirzepatide—have been prescribed (on-and-off label) for weight management, including obesity, along with a reduced caloric diet and increased physical activity. Take precaution with, and read all warnings concerning, GLP-1s, as they may cause serious side effects, including a risk of thyroid c-cell tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC (medullary thyroid carcinoma) or MEN 2 (multiple endocrine neoplasia syndrome). See important warnings & safety info about these medications